Stroking the data: Re-analysis of the NINDS trial

Annals of Emergency Medicine

Volumn 45, Issue 4, 2005, Pages 385-387

  Magid, David ^a,c   Naviaux, Nils ^a   Wears, Robert L ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c CLINICAL RESEARCH UNIT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EMERGENCY CARE; FIBRINOLYTIC THERAPY; HUMAN; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; CONTROLLED CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; METHODOLOGY; NOTE; RANDOMIZED CONTROLLED TRIAL;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; EMERGENCY SERVICE, HOSPITAL; FIBRINOLYTIC AGENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS; SELECTION BIAS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 17844408147     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2005.01.030     Document Type: Editorial

References (35)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
2. T.G. Kwiatkowski, R.B. Libman, and M. Frankel Effects of tissue plasminogen activator for acute ischemic stroke at one year N Engl J Med 340 1999 1781 1787
3. J.S. Meyer, J. Gilroy, and M.E. Barnhart Therapeutic thrombolysis in cerebral thromboembolism: randomized evaluation of intravenous streptokinase C.H. Millikan R.G. Siekert J.P. Whisnat Cerebral Vascular Diseases 1965 Grune and Stratton New York, NY 200 213
4. A.P. Fletcher, N. Alkjaersig, and M. Lewis A pilot study of urokinase therapy in cerebral infarction Stroke 7 1976 135 142
5. M.A. Sloan Thrombolysis and stroke: past and future Arch Neurology 44 1987 748 768
6. W. Hacke, M. Kaste, and C. Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke JAMA 274 1995 1017 1025
7. Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial-Europe Study Group N Engl J Med 335 1996 145 150
8. Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. The Multicenter Acute Stroke Trial-Italy (MAST-I) Group Lancet 346 1995 1509 1514
9. G.A. Donnan, S.M. Davis, and B.R. Chamber Trials of streptokinase in severe acute ischemic stroke JAMA 274 1995 1017 1025
10. H.P. Adams, T.G. Brott, and A.J. Furlan Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association Stroke 27 1996 1711 1718
11. Practice Advisory: thrombolytic therapy for acute ischemic stroke-a summary statement: report of the Quality Standards Subcommittee on the American Academy of Neurology Neurology 47 1996 835 839
12. J.R. Marler, B.C. Tilley, and M. Lu Early stroke treatment associated with better outcome: The NINDS t-PA Stroke Study Neurology 55 2000 1649 1655
13. J. Mann Truths about the NINDS study: setting the record straight West J Med 176 2002 192 194
14. H.P. Adams, P.H. Davis, and E.C. Leira Baseline NIH Stroke Scale strongly predicts outcome after a stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology 55 1999 1648 1655
15. T. Kwiatkowski, R. Libman, and B.C. Tilley The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Ann Emerg Med 45 2005 377 384
16. S.F. Assmann, S.J. Pocock, and L.E. Enos Subgroup analysis and other (mis)uses of baseline data in clinical trials Lancet 355 2000 1064 1069
17. V.M. Montori, R. Jaeschke, and H.J. Schunemann Users' guide to detecting misleading claims in clinical research reports BMJ 329 2004 1093 1096
18. S. Yusuf, J. Wittes, and J. Probstfield Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials JAMA 266 1991 93 98
19. D. Kleindorfer, B. Kissela, and A. Schneider Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study Stroke 35 2004 e27 e29
20. S.R. Tunis, D.B. Stryer, and C.M. Clancy Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy JAMA 290 2003 1624 1632
21. R.E. Glasgow, E. Lichtenstein, and A.C. Marcus Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition Am J Public Health 93 2003 1261 1267
22. P.A. Scott, R. Silbergleit, and S.M. Frederiksen Long-term mortality in stroke patients treated with TPA: emergency physicians vs NINDS physicians [abstract] Acad Emerg Med 10 2003 433
23. I.L. Katzan, A.J. Furlan, and L.E. Lloyd Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience JAMA 283 2000 1151 1158
24. D.M. Bravata, N. Kim, and J. Concato Thrombolysis for acute stroke in routine clinical practice Ann Intern Med 162 2001 1994 2001
25. D. Tanne, P. Verro, and H. Mansbach Overview and summary of Phase IV data on use of t-PA for acute ischemic stroke Stroke Inverventionalist 1 1998 3 5
26. J. Karbalai, A.M. Demchuk, and K.M. Hoyte Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: consequences of protocol violation [abstract] Stroke 30 1999 248
27. A.R. Feinstein, and R.I. Horwitz Problems in the "evidence" of "evidence-based medicine." Am J Med 103 1997 529 535
28. L.W. Green From research to "best practices" in other settings and populations Am J Health Behav 25 2001 165 178
29. T. Brott, and J. Bogousslavsky Treatment of acute ischemic stroke N Engl J Med 343 2000 710 722
30. R.L. Wears Advanced statistics: statistical methods for analyzing cluster and cluster-randomized data Acad Emerg Med 9 2002 330 341
31. J.N.S. Matthews, and D.G. Altman Statistics notes: interaction 2: compare effect sizes not P values BMJ 313 1996 808
32. J.N.S. Matthews, and D.G. Altman Statistics notes: interaction 3: how to examine heterogeneity BMJ 313 1996 862
33. I.G. McDonald Quality assurance and technology assessment: pieces of a larger puzzle J Qual Clin Pract 20 2000 87 94
34. R. Lilford, R. Warren, and D. Braunholtz Action research: a way of researching or a way of managing? J Health Serv Res Policy 8 2003 100 104
35. A. Stoop, H. Heathfield, and M. de Mul Evaluation of patient care information systems: theory and practice M. Berg Health Information Management: Integrating Information Technology in Health Care Work 2004 Routledge London, United Kingdom 206 229